Cell studies link CBD and CBG neuroprotection to the sigma-1 receptor
The Sigma-1 Receptor as a Novel Target in the Neuroprotective Effects of Cannabidiol and Cannabigerol Against Mitochondrial Damage in Cultured Cerebellar Granule Neurons.
AI Summary
This study asked whether the sigma-1 receptor helps explain how CBD and CBG protect neurons from mitochondrial damage. Researchers tested the cannabinoids in cultured cerebellar granule neurons exposed to rotenone, a laboratory model of neuronal toxicity. Blocking the receptor with NE-100 abolished the protective effects of both cannabinoids, supporting a receptor-dependent mechanism in these cells.
The researchers also used molecular docking and computer simulations, which predicted stable binding of CBD and CBG to the receptor; the neutral forms were predicted to bind more strongly than their acidic counterparts. These findings suggest a possible mechanism for neuroprotection in a cell-culture model, but they do not establish a benefit in animals or people. This is an abstract-based summary: the abstract does not report sample sizes or quantitative effect estimates, and the laboratory design cannot show whether these findings translate into clinical effects.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.